Article Details
Retrieved on: 2022-12-23 10:39:59
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
FDA approves Roche's CD20xCD3 bispecific antibody Lunsumio for follicular lymphoma, billed as a challenger to CAR-Ts for the blood cancer.
Article found on: pharmaphorum.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here